Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1373–1380. doi: 10.1158/1055-9965.EPI-09-1282

Table 3.

Distribution of the women by screening test results and disease status [n (%)]

VIA+
297 (12.7)		 VIA−
2,043 (87.3)
PAP+
61 (2.6)		 PAP−
236 (10.1)		 PAP+
283 (12.1)		 PAP−
1,751 (75.1)
HPV+
16 (0.7)		 HPV−
45 (1.9)		 HPV+
23 (1.0)		 HPV−
213 (9.1)		 HPV+
48 (2.1)		 HPV−
235 (10.1)		 HPV+
153 (6.6)		 HPV−
1,598 (68.6)
No. of CIN2+ detected in each diagnostic test category among women receiving colposcopic examination: n/N (%)
↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
4/11 (36.4) 0 1/16 (6.3) 0 6/29 (20.7) 2/131 (1.5) 5/106 (4.7) 1/304 (0.3)